Case Comprehensive Cancer Center
495
50
65
267
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
29.5%
146 terminated/withdrawn out of 495 trials
64.6%
-21.9% vs industry average
3%
13 trials in Phase 3/4
36%
95 of 267 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (495)
Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma
Role: lead
Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial)
Role: lead
ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy
Role: lead
Study of Disulfiram to Reduce Myeloid Immunosuppression and Steroid Dependence in Resectable High Grade Glioma
Role: lead
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Role: lead
Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma
Role: lead
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain
Role: lead
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
Role: lead
Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
Role: lead
Wearable-Triggered Digital Safety Net for Real-Time Monitoring & Intervention in Leptomeningeal Metastasis
Role: lead
Individualized Treatments in Adults With Relapsed/Refractory Cancers
Role: lead
Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas
Role: lead
Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors
Role: lead
Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy
Role: lead
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
Role: lead
Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
Role: lead
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Role: lead
Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
Role: lead
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Role: lead
Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS)
Role: lead